XOMA Corporation (XOMA), a biotech royalty aggregator, said on Tuesday that its Board has authorized first share repurchase program to buy back up to $50 million of shares through January 2027.
"Balanced capital allocation strategy looks to return capital to shareholders while continuing to invest in royalty and milestone acquisitions," XOMA said in a statement.
XOMA was trading down by 1.08 percent at $18.30 per share in the pre-market trade on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.